Mesoblast (MEOBF) FCF Margin (2014 - 2023)
Mesoblast's (MEOBF) quarterly FCF Margin came in at 5932.4% in Q2 2023, up 662330.0% year-over-year from N/an in Q2 2022, and up 247.98% quarter-over-quarter from 4008.87% in Q1 2023.
Analysis
Mesoblast (MEOBF) FCF Margin (2014 - 2023) Analysis & Trends
Mesoblast has disclosed FCF Margin across 10 years of filings, most recently posting 5932.4% for Q2 2023.
- In Q2 2023, FCF Margin rose 662330.0% year-over-year to 5932.4%; the TTM figure through Jun 2023 stood at 848.54% (up 111247.0% YoY), while the FY2026 annual figure was 37.14%, down 25728.0% from the prior year.
- FCF Margin came in at 5932.4% for Q2 2023 at Mesoblast, up from 4008.87% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 5932.4% in Q2 2023 to a low of 4008.87% in Q1 2023.
- Average FCF Margin over 5 years is 372.84%, with a median of 603.07% recorded in 2021.
- The largest YoY upside for FCF Margin was 662330 bps in 2023 against a maximum downside of 323716 bps in 2023.
- Over 5 years, FCF Margin stood at 467.81% in 2019, then slumped by 192 bps to 1364.57% in 2020, then jumped by 62 bps to 515.24% in 2021, then soared by 250 bps to 771.04% in 2022, then soared by 669 bps to 5932.4% in 2023.
- Per Business Quant data, the three most recent FCF Margin figures were 5932.4% in Q2 2023, 4008.87% in Q1 2023, and 771.04% in Q4 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.42 Bn | 112.79 Mn | 59.74% |
| 2 | CRISPR Therapeutics AG | 5.20 Bn | 5.20 Bn | - | -826.50% |
| 3 | Iovance Biotherapeutics | 3.78 Bn | 3.49 Bn | 55.72 Mn | -66.71% |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | -3.46% |
| 5 | uniQure | 3.06 Bn | 3.06 Bn | 5.49 Mn | -497.31% |
| 6 | Beam Therapeutics | 2.68 Bn | 2.68 Bn | - | -13,981.63% |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | -33.11% |
| 8 | Sarepta Therapeutics | 2.35 Bn | 1.55 Bn | 251.87 Mn | 48.98% |
| 9 | Vericel | 2.00 Bn | 1.83 Bn | 56.40 Mn | 18.67% |
| 10 | Mesoblast | 246.02 Mn | 143.11 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | 5,932.40% |
| Mar 31, 2023 | -4,008.87% |
| Dec 31, 2022 | 771.04% |
| Sep 30, 2022 | 950.57% |
| Jun 30, 2022 | -690.90% |
| Mar 31, 2022 | -771.71% |
| Dec 31, 2021 | -515.24% |
| Sep 30, 2021 | 506.37% |
| Jun 30, 2021 | -965.80% |
| Mar 31, 2021 | -1,277.86% |
| Dec 31, 2020 | -1,364.57% |
| Sep 30, 2020 | -2,158.39% |
| Mar 31, 2020 | -116.94% |
| Dec 31, 2019 | -467.81% |
| Sep 30, 2019 | -91.26% |
| Mar 31, 2019 | -1,696.48% |
| Dec 31, 2018 | -104.65% |
| Sep 30, 2018 | -167.95% |
| Jun 30, 2018 | -1,187.53% |
| Mar 31, 2018 | -1,832.06% |